Sensory Integration Disorders in Patients With MS Including Disease Advancement and Relapses in the Last Year
NCT ID: NCT05449574
Last Updated: 2022-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2 participants
OBSERVATIONAL
2022-01-20
2022-06-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160
Influence of Cognitive Function Software Therapy on the Improvement of Manual Skills in Multiple Sclerosis Patients
NCT03693118
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
NCT03177655
Depression and Facial Identity Recognition Abilities in Patients With Multiple Sclerosis
NCT02468765
Investigation of Subclinical Markers of Multiple Sclerosis
NCT04604041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
people with MS
People with MS with relapsing-remitting form
Scale for the Assessment of Sensory Integration in Adults
In people with MS and people with health of similar age, a test was performed to assess sensory integration in adults
healthy people
people from the age of 30-45 years old
Scale for the Assessment of Sensory Integration in Adults
In people with MS and people with health of similar age, a test was performed to assess sensory integration in adults
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scale for the Assessment of Sensory Integration in Adults
In people with MS and people with health of similar age, a test was performed to assess sensory integration in adults
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 30-45 years
* without diagnosed disorders of sensory integration and MS
Exclusion Criteria
* diagnosed with Ms
30 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pomeranian Medical University Szczecin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wioletta Pawlukowska, dr hab.
Role: STUDY_CHAIR
Department of Neurology, Pomeranian Medical University, Szczecin, Poland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departmen of Neurology
Szczecin, Unii Lubelskiej, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PUM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.